CVnCoV Completed Phase 3 Trials for Infections, Coronavirus / Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04860258A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19